2025
Network-based drug optimization toward the treatment of Parkinson's disease: NRF2, MAO-B, oxidative stress, and chronic neuroinflammation
Journal of Medicinal chemistry. DOI: 10.1021/acs.jmedchem.4c02659
Exploring the broad-spectrum activity of carbohydrate-based Iberin analogues: From anticancer effect to antioxidant properties
European Journal of Medicinal Chemistry. DOI: 10.1016/j.ejmech.2025.117469
NRF2 activation by 6-MSITC increases the generation of neuroprotective, soluble alpha-amyloid precursor protein by inducing the metalloprotease gene ADAM17
Free Radical Biology in Medicine. DOI: 10.1016/j.freeradbiomed.2024.11.048
Proteostasis decline and redox imbalance in age-related diseases: The therapeutic potential of NRF2.
Biomolecules. DOI: 10.3390/biom15010113
Health position paper and redox perspectives - Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases.
Redox Biology. DOI: 10.1016/j.redox.2025.103569
Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases.
Redox Biology. DOI: 10.1016/j.redox.2024.103464
2024
TRP14 is the rate limiting enzyme for intracellular cystine reduction and regulates proteome cysteinylation.
EMBO Journal. DOI: 10.1038/s44318-024-00117-1
The mitochondrial Na+/Ca2+ exchanger NCLX is implied in the activation of hypoxia-inducible factors.
Redox Biol. DOI: 10.1016/j.redox.2024.103364
The NRF2 inducer CDDO-2P-Im provokes a reduction in amyloid? Levels in Alzheimer’s disease model mice.
J Biochem. DOI: 10.1093/jb/mvae060
Discovery of a potent melatonin-based inhibitor of quinone reductase-2 with neuroprotective and neurogenic properties.
Eur J Med Chem. DOI: 10.1016/j.ejmech.2024.116763
Biomarkers of NRF2 signalling: Current status and future challenges.
Redox Biol. DOI: 10.1016/j.redox.2024.103134
Inhibition of glycogen synthase kinase-3 enhances NRF2 protein stability, nuclear localisation and target gene transcription in pancreatic beta cells.
Redox Biol. DOI: 10.1016/j.redox.2024.103117
Innovative pathological network-based multitarget approaches for Alzheimer’s disease treatment.
Med Res Rev. DOI: 10.1002/med.22045
Adipose tissue as a therapeutic target for vascular damage in Alzheimer’s disease.
Br J Pharmacol. DOI: 10.1111/bph.16243
Specific targeting of the NRF2/β-TrCP axis promotes beneficial effects in NASH.
Redox Biol. DOI: 10.1016/j.redox.2024.103027
The Melatonin Derivative ITH13001 Prevents Hypertension and Cardiovascular Alterations in Angiotensin II-Infused mice.
J Pharmacol Exp Ther. DOI: 10.1124/jpet.123.001586
2023
Drug repurposing on Alzheimer’s disease through modulation of NRF2 neighborhood.
Redox Biol. DOI: 10.1016/j.redox.2023.102881
Redox regulation of microglial inflammatory response: Fine control of NLRP3 inflammasome through Nrf2 and NOX4.
Antioxidants. DOI: 10.3390/antiox12091729
Adipose tissue as a therapeutic target for vascular damage in Alzheimer’s disease.
Br J Pharmacol. DOI: 10.1111/bph.16243
Mechanisms of NURR1 regulation: consequences for its biological activity and involvement in pathology.
Int J Mol Sci. DOI: 10.3390/ijms241512280
Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets.
Redox Biol. DOI: 10.1016/j.redox.2023.102603
The transcription factor NRF2 has epigenetic regulatory functions modulating HDACs, DNMTs, and miRNA biogenesis.
Antioxidants. DOI: 10.3390/antiox12030641
8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin’s antidepressant profile: synthesis, biological evaluation and docking studies.
Eur. J. Med. Chem. DOI: 10.1016/j.ejmech.2023.115091
Introduction to special issue on «Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases».
Free Radic Biol Med. DOI: 10.1016/j.freeradbiomed.2022.12.100
Small synthetic hyaluronan disaccharide BIS014 mitigates neuropathic pain in mice.
J Pain. DOI: 10.1016/j.jpain.2022.07.014
Cytotoxicity models in chromaffin cells to evaluate neuroprotective compounds.
Methods Mol Biol. DOI:https://pubmed.ncbi.nlm.nih.gov/36205906/https://doi.org/10.1002/med.21925
2022
Impairment in novelty-promoted memory via behavioral tagging and capture before apparent memory loss in a knock-in model of Alzheimer’s disease.
Sci Rep. DOI: 10.1038/s41598-022-26113-1
The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and β-TrCP-NRF2 interactions in cancer chemoresistance.
Free Radic Biol Med. DOI: 10.1016/j.freeradbiomed.2022.09.023
Overlooked and valuable facts to know in the NRF2/KEAP1 field.
Free Radic Biol Med. DOI: 10.1016/j.freeradbiomed.2022.08.044
Microglial Hemoxygenase-1 deletion reduces inflammation in the retina of old mice with tauopathy.
Antioxidants. DOI: 10.3390/antiox11112151
Dipeptide repeat pathology in c9orf72-ALS is associated with redox, mitochondrial and NRF2 pathway imbalance.
Antioxidants. DOI: 10.3390/antiox11101897
Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors.
J Med Chem. DOI:10.1021/acs.jmedchem.2c00515
Pros and cons of NRF2 activation as adjunctive therapy in rheumatoid arthritis.
Free Radic Biol Med. DOI: 10.1016/j.freeradbiomed.2022.08.012
An inhibitor of interaction between the transcription factor NRF2 and the E3 ubiquitin ligase adapter β-TrCP delivers anti-inflammatory responses in mouse liver.
Redox Biol. DOI: 10.1016/j.redox.2022.102396
KEAP1-NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential.
Medicinal Research Reviews. DOI:https://doi.org/10.1002/med.21925
Protective actions of nuclear factor erythroid 2-related factor 2 (NRF2) and downstream pathways against environmental stressors.
Free Radic Biol Med. DOI: 10.1016/j.freeradbiomed.2022.05.016
Loss of KEAP1 causes an accumulation of nondegradative organelles.
Antioxidants. DOI: 10.3390/antiox11071398
Brain-protective mechanisms of transcription factor NRF2: toward a common strategy for neurodegenerative diseases.
Annu Rev Pharmacol Toxicol. DOI: http://10.1146/annurev-pharmtox-052220-103416
Antinociceptive and modulatory effect of pathoplastic changes in spinal glia of a TLR4 /CD14 blocking molecule in two models of pain in rat.
Biomed Pharmacother. DOI: 10.1016/j.biopha.2022.112986
Transcription factor NRF2 participates in cell cycle progression at the level of G1/S and mitotic checkpoints.
Antioxidants. DOI: http://10.3390/antiox11050946
Novel series of dual NRF2 inducers and selective MAO-B inhibitors for the treatment of Parkinson’s disease.
Antioxidants. DOI: http://10.3390/antiox11020247
Implication of type 4 NADPH oxidase (NOX4) in tauopathy.
Redox Biology. DOI: 10.1016/j.redox.2021.102210
Antinociceptive and modulatory effect of pathoplastic changes in spinal glia of a TLR4/CD14 blocking molecule in two models of pain in rat.
Biomed. Pharmacother. DOI: https://doi.org/10.1016/j.biopha.2022.112986
Resveratrol-based MTDLs to stimulate defensive and regenerative pathways and block early events in neurodegenerative cascades.
J. Med. Chem. DOI: https://doi.org/10.1021/acs.jmedchem.1c01883
Curcumin-piperlongumine hybrids with a multitarget profile elicit neuroprotection in in vitro models of oxidative stress and hyperphosphorylation.
Antioxidants. DOI: http://10.3390/antiox11010028
Enantioselective synthesis and pharmacological evaluation of AZA-CGP37157-Lipoic Acid hybrids for the treatment of Alzheimer’s disease.
Antioxidants. DOI: 10.3390/antiox11010112
2021
Central Activation of Alpha7 Nicotinic Signaling Attenuates LPS-Induced Neuroinflammation and Sickness Behavior in Adult but Not in Aged Animals.
Molecules. DOI: 10.3390/molecules26082107
Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice.
Nature Communcations. DOI:http://10.1038/s41467-021-22501-9
Bisavenathramide analogues as nrf2 inductors and neuroprotectors in in vitro models of oxidative stress and hyperphosphorylation.
Antioxidants. DOI: http://10.3390/antiox10060941
Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration.
Acta Neuropathol Commun. DOI: http://10.1186/s40478-021-01196-5
NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS.
Free Radical Biology and Medicine. DOI: http://10.1016/j.freeradbiomed.2021.07.022
Intracellular calcium and inflammatory markers, mediated by purinergic stimulation, are differentially regulated in monocytes of patients with major depressive disorder.
Neuroscience Letters. DOI:http://10.1016/j.neulet.2021.136275
Enhanced stability and bioactivity of natural anticancer topoisomerase i inhibitors through cyclodextrin complexation.
Pharmaceutics. DOI: http://10.3390/pharmaceutics13101609
α-Synuclein Induces the GSK-3-Mediated Phosphorylation and Degradation of NURR1 and Loss of Dopaminergic Hallmarks.
Molecular Neurobiology. DOI: http://10.1007/s12035-021-02558-9
Synthesis and in vitro study of nitro- and methoxy-2-phenylbenzofurans as human monoamine oxidase inhibitors.
Bioorg. DOI: https://doi.org/10.1016/j.bioorg.2020.104616
Protective role of microglial HO-1 blockade in aging: implication of iron metabolism.
Redox Biology. DOI: 10.1016/j.redox.2020.101789
2020
Cognitive enhancement, tau phosphorylation reduction and neuronal protection by the treatment of a LRRK2 inhibitor in a taoupathy mouse model.
Neurobiology of Aging. DOI: 10.1016/j.neurobiolaging.2020.09.006
Melatonin-sulforaphane hybrid ITH12674 attenuates glial response in vivo by blocking LPS binding to MD2 and receptor oligomerization.
Pharmacological Research. DOI: 10.1016/j.phrs.2019.104597
Nordihydroguaiaretic Acid: From Herbal Medicine to Clinical Development for Cancer and Chronic Diseases.
Frontiers in Pharmacology. DOI: http://10.3389/fphar.2020.00151
Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties.
Eur. J. Med. Chem. DOI: 10.1016/j.ejmech.2020.112090
Optical control of muscular nicotinic channels with azocuroniums, photoswitchable azobenzenes bearing two N-methyl-N-carbocyclic quaternary ammonium groups.
Eur. J. Med. Chem. DOI: 10.1016/j.ejmech.2020.112403
Aza-CGP37157-lipoic hybrids designed as novel Nrf2-inducers and antioxidants exert neuroprotection against oxidative stress and show neuroinflammation inhibitory properties.
Drug Development Research. DOI: 10.1002/ddr.21618
NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases.
Biomolecules. DOI: 10.3390/biom10060904
Aging and Progression of Beta-Amyloid Pathology in Alzheimer’s Disease Correlates with Microglial Heme-Oxygenase-1 Overexpression.
Antioxidants. DOI: 10.3390/antiox9070644
Na+ controls hypoxic signalling by the mitochondrial respiratory chain.
Nature. DOI 10.1038/s41586-020-2551-y
Antioxidant, anti-inflammatory and neuroprotective profiles of novel 1,4-dihydropyridine derivatives for the treatment of Alzheimer’s disease.
Antioxidants. DOI: 0.3390/antiox9080650
When It Comes to an End: Oxidative Stress Crosstalk with Protein Aggregation and Neuroinflammation Induce Neurodegeneration.
Antioxidants. DOI: 10.3390/antiox9080740
Protective role of microglial HO-1 blockade in aging: Implication of iron metabolism.
Redox Biology. DOI: 10.1016/j.redox.2020.101789
Wip modulates oxidative stress through NRF2/KEAP1 in glioblastoma cells.
Antioxidants. DOI: http://10.3390/antiox9090773
Can Activation of NRF2 Be a Strategy against COVID-19?
Trends in Pharmacological Sciences. DOI: 10.1016/j.tips.2020.07.003
Perspectives on the Clinical Development of NRF2-Targeting Drugs.
Handbook of Experimental Pharmacology (Chapter). DOI: 10.1007/164_2020_381
New Nrf2-inducer compound ITH12674 slows the progression of retinitis pigmentosa in the mouse model rd10.
Cellular Physiology And Biochemistry. DOI: http://10.33594/000000210
2019
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases.
Nat Rev Drug Discov. DOI: 10.1038/s41573-018-0008-
New flavonoid – N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties.
J. Enzyme Inhib. Med. Chem. DOI: 10.1080/14756366.2019.1581184
Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development.
Oxid Med Cell Longev. DOI: 10.1155/2019/9372182
Pharmacological doses of melatonin impede cognitive decline in tau-related Alzheimer models, once tauopathy is initiated, by restoring the autophagic flux.
Journal of Pineal research. DOI: http://10.1111/jpi.12578
Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy.
Redox Biol. DOI: 10.1016/j.redox.2017.10.010
Neurogenic and neuroprotective donepezil-flavonoid hybrids wit sigma-1 affinity and inhibition of key enzymes in Alzheimer’s disease.
Eur. J. Med. Chem. DOI: https://doi.org/10.1016/j.ejmech.2018.07.026
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach.
Pharmacol Rev. DOI:10.1124/pr.117.014753
Transcription factor NFE2L2/NRF2 modulates chaperone-mediated autophagy through the regulation of LAMP2A.
Autophagy. DOI: 10.1080/15548627.2018.1474992
Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy.
Redox Biol. DOI: 10.1016/j.redox.2018.07.006
Multi-target-directed ligands for Alzheimer´s disease: discovery of chromone-based monoamine oxidase/cholinesterase inhibitors.
Eur. J. Med. Chem. DOI: 10.1016/j.ejmech.2018.07.056
2018
PUBLICACIONES
Necesitamos su consentimiento para cargar las traducciones
Utilizamos un servicio de terceros para traducir el contenido del sitio web que puede recopilar datos sobre su actividad. Por favor revise los detalles en la política de privacidad y acepte el servicio para ver las traducciones.